Clinical Trials Directory

Trials / Completed

CompletedNCT03363113

Outcome of Botulinum Toxin Treatment for Oromandibular Dystonia

Status
Completed
Phase
Study type
Observational
Enrollment
240 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Symptoms of oromandibular dystonia can be alleviated by injections of botulinum toxin. The scope of this study is to describe the efficacy of this procedure, by a retrospective systematic review of patients medical charts

Conditions

Interventions

TypeNameDescription
DRUGBotulinum ToxinsInjection of botulinum toxin in the muscles affected by oromandibular dystonia

Timeline

Start date
2016-01-01
Primary completion
2016-04-01
Completion
2016-07-12
First posted
2017-12-06
Last updated
2017-12-06

Source: ClinicalTrials.gov record NCT03363113. Inclusion in this directory is not an endorsement.